Google backs PP405, the lotion that makes hair grow
Google is funding PP405, a phase II drug against baldness. Miracle or business? An analysis of the debate over its effectiveness and risks.
English · Original discussion in Spanish · Published
PP405, Google's promise against baldness: revolution or mirage?
Google has put its financial and technological machinery at the service of hair growth. PP405, a topical drug in phase II clinical trials, has generated excitement in alopecia communities around the world. But behind the slogan of 'the dreamed-of revolution' lie reasonable doubts: from side effects to the track record of failures in similar treatments. The debate is not only medical but economic: the baldness market moves billions, and an effective solution would be a colossal business. However, recent history has taught us to distrust miracle pills.
What is behind PP405?
PP405 is a topical treatment, not an oral drug like finasteride. It acts on the hair trinc by stimulating growth, and the phase I results were promising. However, phase II has not yet concluded, and experts urge caution. Skeptics recall the case of Ozempic: a drug that promised miracles and ended up linked to serious side effects. Although there is no evidence that PP405 carries similar risks, the analogy serves as a warning about the hype. The scientific community insists that alopecia is complex and that many treatments that seem to work in the lab fail in humans.
The business of hair hope
Google is not a pharmaceutical company, but it invests in biotech R&D as a strategic bet. If PP405 reaches the market, the return could be enormous: the global market for hair treatments is estimated to exceed 10,000 million dollars a year. However, the road is littered with failures. The article from El País shared in the discussion warns that, for now, PP405 does not replace hair transplants. The question is whether Google is willing to take on the risk of a long-term investment or whether this is a marketing operation.
While bald people wait for their miracle, Google keeps playing the biotechnology roulette. PP405 may be a success or another failure in the long history of hair treatments. The answer, as always, will be given by the trials and by time.
Related discussions in the forum
Google has put its financial and technological machinery at the service of hair growth. PP405, a topical drug in phase II clinical trials, has generated excitement in alopecia communities around the world. But behind the slogan of 'the dreamed-of revolution' lie reasonable doubts: from side effects to the track record of failures in similar treatments. The debate is not only medical but economic: the baldness market moves billions, and an effective solution would be a colossal business. However, recent history has taught us to distrust miracle pills.
What is behind PP405?
PP405 is a topical treatment, not an oral drug like finasteride. It acts on the hair trinc by stimulating growth, and the phase I results were promising. However, phase II has not yet concluded, and experts urge caution. Skeptics recall the case of Ozempic: a drug that promised miracles and ended up linked to serious side effects. Although there is no evidence that PP405 carries similar risks, the analogy serves as a warning about the hype. The scientific community insists that alopecia is complex and that many treatments that seem to work in the lab fail in humans.
The business of hair hope
Google is not a pharmaceutical company, but it invests in biotech R&D as a strategic bet. If PP405 reaches the market, the return could be enormous: the global market for hair treatments is estimated to exceed 10,000 million dollars a year. However, the road is littered with failures. The article from El País shared in the discussion warns that, for now, PP405 does not replace hair transplants. The question is whether Google is willing to take on the risk of a long-term investment or whether this is a marketing operation.
While bald people wait for their miracle, Google keeps playing the biotechnology roulette. PP405 may be a success or another failure in the long history of hair treatments. The answer, as always, will be given by the trials and by time.
Related discussions in the forum
- Lorca...NETFLIX buys the Javis' film at Cannes... the lgtb civil war as seen by the pzoe · 154 replies
- Why didn't Zapatero take the jewels and other stuff out of the safe if he knew they were going to search it? Same for the PSOE at Ferraz · 18 replies
- Is Pedro Sanchez out of his mind or what? · 81 replies
- Félix Bolaños announces a massive call for entry into the judicial and prosecutorial career. · 18 replies
Also available in: Deutsch
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (20 replies).
More summaries
-
Spanish mortgages up 10.8%: best June since 2010
Mortgages in Spain posted their best June since 2010 with 45,907 signings, up 10.8%. Is the market consolidating or is it a bubble?
-
Google alternatives: the search engine that brings back the 2000s internet
Yandex, DuckDuckGo and other search engines return results that Google hides. Going back to an uncensored search engine is no longer nostalgia, it's a necessity.
-
Marlo, 23: the job that eats his life
Marlo, 23, describes in a video his first job and the feeling that the workday eats the day. A debate about pay, housing and effort.
-
Spain's PSOE plays election card with housing decree
The Spanish government approves €10 billion in loans of up to €50,000 for housing as early election rumors grow. The IBEX surged on the news.
-
El Corte Inglés Toy Catalogs Resold as Stock Vanishes
El Corte Inglés toy catalogs sell out in days, sparking resale. A second batch also disappeared quickly.
-
Spain arrests 14 far-right members before protest
Spanish police detained 14 Núcleo Nacional members, most released hours later, sparking debate on judicial tactics.